Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Menarini Asia-Pacific strengthens Men's Health portfolio in China with acquisition of Cialis(R) (Tadalafil) from Lilly 2021-07-22 10:00
Antengene Announces The Approval by Human Research Ethics Committee in Australia and to Start the Phase 1 Trial of ATG-101 (the first PD-L1/4-1BB bispecific antibody) in Solid Tumors and Non-Hodgkin Lymphoma 2021-07-22 09:27
Joysbio's COVID-19 RAPID tests detect NEW SARS-COV-2 variants 2021-07-22 08:37
China NMPA Approves Phase III Clinical Trial of ASC40 Combined with Bevacizumab for Treatment of Patients with Recurrent Glioblastoma 2021-07-22 08:30
Sensor Technologies for Pressure Injury Prevention Improve Outcomes and Operational Efficiency for Hospitals 2021-07-22 00:30
Kazia Calls for Increased Focus on Brain Cancer Research this GBM Awareness Day 2021-07-21 22:00
AnchorDx's Non-invasive Bladder Cancer Early Detection Test, UriFind, Earns "Breakthrough Device Designation" from FDA 2021-07-21 21:02
ArcScan, Inc. Signs Definitive Agreement for $11.15 Million Preferred Series B Investment with Shanghai Haohai Biological Technology Ltd. 2021-07-21 20:33
Ascentage Pharma's MDM2-p53 Inhibitor APG-115 (Alrizomadlin) Granted an Orphan Drug Designation by the FDA for the Treatment of Stage IIB-IV Melanoma, Marking the Twelfth Obtained by the Company 2021-07-21 18:37
Clarivate Introduces Cortellis Supply Chain Network™, a Revolutionary Digital Partnering Solution 2021-07-21 16:05
Notice to the Annual General Meeting of Elekta AB (publ) 2021-07-21 15:06
Knowledge Catalyst to Power Paspor Sehat in issuing Digital Health Credentials in Indonesia for Travelers 2021-07-21 14:00
MedPharm Implements the Peregrine Connect NetSuite PSA Add-in for Microsoft Project to Accurately Forecast Revenue and Cut Manual Labor by 80% 2021-07-21 09:00
Direct Biologics Announces FDA Approval for Proceeding With Second ExoFlo IND for Post-Acute COVID-19 Syndrome and Chronic Post-COVID-19 Syndrome 2021-07-21 05:44
ExoFlo™ From Direct Biologics Fulfills Urgent Medical Need in COVID-19 Treatment 2021-07-21 03:43
OriCiro Announces ¥1 Billion Series B Financing to Advance Cell-Free DNA Technology for Innovative Therapeutics and Synthetic Biology 2021-07-20 23:00
Terumo and UMCU strengthen their partnership to develop solutions in Interventional Oncology 2021-07-20 22:54
Harbour BioMed Appoints Yingying Chen, PhD, as Chief Financial Officer 2021-07-20 21:53
Interaxon Partners with Celéri Health to Validate Chronic Pain Intervention 2021-07-20 21:00
Kineta and Samsung Biologics Announce Development and Manufacturing Agreement for Anti-VISTA Antibody Immunotherapy 2021-07-20 20:00
1 369 370 371 372 373 896